Guggenheim Capital’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-25,093
Closed -$193K 2789
2017
Q4
$193K Sell
25,093
-10,701
-30% -$89.2K ﹤0.01% 2574
2017
Q3
$299K Sell
35,794
-12,836
-26% -$80K ﹤0.01% 2553
2017
Q2
$207K Sell
48,630
-15,239
-24% -$61.1K ﹤0.01% 2638
2017
Q1
$243K Sell
63,869
-19,668
-24% -$77.9K ﹤0.01% 2588
2016
Q4
$334K Sell
83,537
-34,788
-29% -$142K ﹤0.01% 2555
2016
Q3
$534K Sell
118,325
-31,125
-21% -$160K ﹤0.01% 2361
2016
Q2
$732K Sell
149,450
-25,614
-15% -$145K ﹤0.01% 2224
2016
Q1
$2.06M Sell
175,064
-161,385
-48% -$2.24M 0.01% 1550
2015
Q4
$6.7M Buy
336,449
+109,484
+48% +$2.7M 0.02% 899
2015
Q3
$5.51M Sell
226,965
-112,665
-33% -$2.93M 0.02% 985
2015
Q2
$8.65M Buy
339,630
+58,028
+21% +$1.54M 0.02% 902
2015
Q1
$6.77M Sell
281,602
-11,012
-4% -$279K 0.02% 1025
2014
Q4
$6.56M Buy
292,614
+30,800
+12% +$801K 0.02% 1005
2014
Q3
$7.19M Buy
261,814
+15,557
+6% +$470K 0.02% 1035
2014
Q2
$7.83M Buy
246,257
+18,745
+8% +$558K 0.02% 975
2014
Q1
$5.88M Buy
227,512
+33,427
+17% +$912K 0.02% 1045
2013
Q4
$5.05M Buy
194,085
+14,549
+8% +$407K 0.02% 1088
2013
Q3
$4.9M Buy
179,536
+1,422
+0.8% +$44.7K 0.02% 1107
2013
Q2
$6.48M Buy
+178,114
New +$6.4M 0.03% 945

Other funds holding CLMT

Guggenheim Capital's CLMT Position: Q1 2018 in Review

Guggenheim Capital sold out of Calumet Specialty Products (CLMT) in Q1 2018, closing a stake of 25,093 shares — an estimated $193K sold.

Guggenheim Capital first reported a position in CLMT in Q2 2013 and held it in 19 quarters. The position peaked at $8.65M in Q2 2015. 72 funds tracked by Wall St. Rank hold CLMT as of Q1 2018.

  • Guggenheim Capital reported no remaining Calumet Specialty Products position as of Q1 2018 after selling out during the quarter.
  • Guggenheim Capital sold 25,093 Calumet Specialty Products shares in Q1 2018, an estimated $193K.
  • Guggenheim Capital first reported a position in Calumet Specialty Products in Q2 2013 and held it in 19 quarters.
  • Guggenheim Capital's Calumet Specialty Products position peaked at $8.65M in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2018.

Based on Guggenheim Capital's 13F filing for Q1 2018, filed 15 May 2018.